Product Images Ipratropium Bromide
View Photos of Packaging, Labels & Appearance
- 97e130d5-figure-01 - 97e130d5 figure 01
- 97e10d5-figure-02 - 97e130d5 figure 02
- 97e130d5-figure-03 - 97e130d5 figure 03
- 97e130d5-figure-04 - 97e130d5 figure 04
- f05 - Screenshot 2025 03 07 140115
- Figure 06 - Screenshot 2025 03 07 141620
- Figure 07 - Screenshot 2025 03 07 142042
- Figure 08 - Screenshot 2025 03 07 142840
Product Label Images
The following 8 images provide visual information about the product associated with Ipratropium Bromide NDC 64980-640 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
97e130d5-figure-01 - 97e130d5 figure 01
97e10d5-figure-02 - 97e130d5 figure 02
97e130d5-figure-03 - 97e130d5 figure 03
97e130d5-figure-04 - 97e130d5 figure 04
f05 - Screenshot 2025 03 07 140115
This is a description of Ipratropium Bromide Inhalation Solution, USP 0.02%, with a concentration of 0.5 mg/2.5 mL. Each low-density polyethylene vial contains 25 ml of the solution. The medication is intended for oral inhalation only and should not be injected. The solution is preserved with an isotonic saline solution and should be stored between 15°C and 30°C (59°F and 86°F). The dosage instructions should be followed as per the prescribing information provided. The solution is sterile and comes in 5 packs of 25mL unit dose vials. Pharmacists are instructed to detach the patient instructions from the package insert and dispense the solution accordingly.*
Figure 06 - Screenshot 2025 03 07 141620
This is the description: "Ipratropium Bromide Inhalation Solution, USP 0.02%, 0.5 mg/2.5 ml for oral inhalation only. Not for nebulization. The text also includes a CAD File number: 12508."*
Figure 07 - Screenshot 2025 03 07 142042
This is a description of Ipratropium Bromide Inhalation Solution, USP 0.02%, with a recommended dosage of 0.5 mg per 25 mL for oral inhalation use only. It emphasizes not to use this solution for injection and provides some details on administration.*
Figure 08 - Screenshot 2025 03 07 142840
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
